MARKET WIRE NEWS

BMEZ: Recession Fears Making You Sick? Buy This High-Yield Healthcare Fund

Source: SeekingAlpha

2025-03-11 13:02:05 ET

Summary

  • Fear of a looming recession has investors seeking defensive sectors like Healthcare, which benefits from positive secular trends and offers high-yield dividend stocks.
  • The BlackRock Health Sciences Term Trust provides high-yield income through healthcare equities and an option writing strategy, with a current distribution rate of 13.6%.
  • BMEZ's top holdings, including Intuitive Surgical, argenx SE, and Alnylam Pharmaceuticals, show strong growth potential, despite past underperformance due to market conditions.
  • Long-term investment in BMEZ is attractive due to aging demographics, medical innovation, and technological advancements, making it a Buy for income-focused investors.

Fear of a looming recession is on the minds of investors once again. The Nasdaq index crumbled by 4% on March 10 with the tech selloff intensifying since the start of the year. The Dow (DJI) and the S&P 500 (SP500) were both down over 2% as well, with the S&P 500 on pace to close below the 200-day moving average for the first time since November 2023. In addition, the VIX moved to its highest intraday level in eight months. Volatility has returned to the markets, and it is time for investors to get defensive....

Read the full article on Seeking Alpha

For further details see:

BMEZ: Recession Fears Making You Sick? Buy This High-Yield Healthcare Fund
BlackRock Health Sciences Term Trust of Beneficial Interest

NASDAQ: BMEZ

BMEZ Trading

1.74% G/L:

$14.64 Last:

219,134 Volume:

$14.58 Open:

COSM Ad 300

BMEZ Latest News

BMEZ Stock Data

$200,928,581
12,560,000
N/A
118
N/A
Asset Management Services
Finance
US
Wilmington

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App